Literature DB >> 1713216

Human immunodeficiency virus reverse transcriptase. Effect of primer length on template-primer binding.

J E Reardon1, E S Furfine, N Cheng.   

Abstract

Poly(rA).oligo(dT)n binding to human immunodeficiency virus type-1 reverse transcriptase heterodimer (p66-p51) was primer length-dependent. The estimated Kd for (n = 10-14) was 20-30 nM and for (n = 16-20) was 0.11-0.14 nM. Gel electrophoretic analysis of the patterns of primer extension was consistent with an abrupt change in the Kd between a primer length of 14 and 16 nucleotides. Further, the rate constant for dissociation of the reverse transcriptase-template-primer complex was determined from steady state kinetics and enzyme-template-primer trapping experiments to be independent of primer length. Thus, the abrupt change in Kd was most likely due to a change in the rate constant for formation of the reverse transcriptase-template-primer complex. A similar shift in the Kd for template-primer binding was observed with poly(dA).oligo(dT)n. Reverse transcriptase homodimer (p66) catalyzed the incorporation of dTMP into poly(rA).oligo(dT)n with the same primer length dependence observed for the heterodimer. In contrast, binding of the p51 homodimer to poly(rA).oligo(dT)n was independent of primer length. Thus, the RNase H domain may contribute to reverse transcriptase heterodimer or p66 homodimer binding to template-primers in which the primer length is greater than 14 nucleotides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713216

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Tighter binding of HIV reverse transcriptase to RNA-DNA versus DNA-DNA results mostly from interactions in the polymerase domain and requires just a small stretch of RNA-DNA.

Authors:  William P Bohlayer; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

2.  1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Authors:  S M Daluge; S S Good; M B Faletto; W H Miller; M H St Clair; L R Boone; M Tisdale; N R Parry; J E Reardon; R E Dornsife; D R Averett; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis.

Authors:  A M Martín-Hernández; E Domingo; L Menéndez-Arias
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

4.  Deoxyribonucleotide-containing RNAs: a novel class of templates for HIV-1 reverse transcriptase.

Authors:  S O Gudima; E G Kazantseva; D A Kostyuk; I L Shchaveleva; O I Grishchenko; L V Memelova; S N Kochetkov
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

5.  Unequal human immunodeficiency virus type 1 reverse transcriptase error rates with RNA and DNA templates.

Authors:  J C Boyer; K Bebenek; T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities.

Authors:  V Gopalakrishnan; J A Peliska; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

7.  RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.

Authors:  A Telesnitsky; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

8.  Contributions of DNA polymerase subdomains to the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  J S Smith; K Gritsman; M J Roth
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile.

Authors:  S M Daluge; D J Purifoy; P M Savina; M H St Clair; N R Parry; I K Dev; P Novak; K M Ayers; J E Reardon; G B Roberts
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

10.  Functional roles of carboxylate residues comprising the DNA polymerase active site triad of Ty3 reverse transcriptase.

Authors:  Arkadiusz Bibillo; Daniela Lener; George J Klarmann; Stuart F J Le Grice
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.